BACKGROUND: Multiplex polymerase chain reaction al lows amplification of multiple target sequences of a ge nome under identical conditions in a single tube. This "one shot" polymerase chain reaction detection is time and cost effective when large or multiple genes, with many target fragments are investigated. This is applicable for retino blastoma susceptibility gene having 27 exons with recur rent mutations reported at most of the 12 CGA codons. MATERIALS AND METHODS: Multiplex polymerase chain reaction assay for the amplification of 12 CGA codons, which constitutes about 50 % of retinoblastoma suscepti bility gene mutations has been designed. The time and cost (includes only reagent cost) involved in both multiplex and uniplex polymerase chain reaction was also calculated. RESULTS: Twelve CGA codons were multiplexed in 5 in stead of 12 uniplex polymerase chain reactions, which took 36 hours and 9.78 US$ whereas multiplex polymerase chain reaction took 15 hours and 6.88 US$. Multiplex poly merase chain reaction method saved 58.3% of time and 29.6% of cost over uniplex polymerase chain reaction. CONCLUSION: Saving time by more than half and cost by nearly a third would help clinicians and geneticists while counseling retinoblastoma patients.
Introduction
Retinoblastoma is a rare tumor that arises when both RB1 gene alleles are mutated. The developing retina has 4×10 6 cells, but only about 1 in 10 6 cells actually give rise to a tumor cell. Mutations in RB1 usually result in disruption of the protein product and cause retinoblastoma. [1, 2] One of the major goals in treatment of patients with Sankara Nethralaya, Chennai -600 006, India retinoblastoma is early detection of retinoblastoma that helps in saving the vision in the affected eye. Despite the use of modern molecular techniques, there have been several obstacles to achieve the goal, because the retinoblastoma gene is very large and mutations occur throughout the gene with no single 'hot spot'. [3] Five to 8 percentof mutations in RB1 gene can be observed cytogenetically, which includes predominantly deletions but rarely insertions and translocations. [3] Remaining alterations are submicroscopic, which includes nonsense mutations, frame-shift mutations, missense mutations, in frame deletions, intron nucleotide change (alters splicing), loss of heterozygosity, or methylation of the promoter region.
From various reports throughout the world it is found that in DNA mutations, non-sense and frame-shift mutations occur in 78% of retinoblastoma patients, intronic changes in 12% of patients, missense and small in-frame deletions in 8% of patients and nucleotide changes in the promoter region in 2% of patients. [4] Non sense and frame-shift mutations result in premature termination of translation resulting in a truncated protein product, which cannot regulate the cell cycle. These mutations are more disruptive to protein function than other types of mutations. [4, 5] Cowell et al [6] has shown that the most common point mutation in the RB1 gene in retinoblastoma tumors is C->T transition and majority of these occur in CGA codons. As a result of this mutation, a TGA stop codon is generated directly which has been predicted to result in the absence of a functional protein. Fourteen CGA codons in the RB1 gene has been analysed for mutations in 113 patients with bilateral retinoblastoma. Six of these sites, C->T mutations in CGA codons alter a restriction enzyme site, which makes their identification relatively straightforward. [6] As majority of single base substitutions (76%) in RB1 gene are recurrent CpG transitions at 12 of the 15 CGA codons within the open reading frame, [4, 7] they can be identified by a relatively quick survey of the CGA codons.
A mPCR (multiplex polymerase chain reaction) method for the amplification of 12 CGA codons of RB1 gene was designed, that allows rapid identification of RB1 mutations. The main advantage of mPCR is speed of analysis followed by economy on sample and reagents than uPCR (uniplex polymerase chain reaction) performed; less Taq polymerase, dNTPs and buffer; consumables including DNA. Simplicity of the method and sensitivity of the detection adds to the advantages of mPCR. According to this principle, we designed an extensive mPCR reaction for 12 CGA codons within RB1. Using this approach, we were able to save both time and cost.
Materials and Methods
The laboratory technique includes DNA extraction and multiplex PCR followed by 2% agarose gel electrophoresis.
DNA Extraction
DNA has been extracted from the venous blood collected from unrelated control subjects by standard phenol chloroform method. For multiplex PCR, 12 CGA codons were separated in to five groups as given in Table 1 
Uniplex PCR

Results
Uniplex PCR
Polymerase chain reaction has been standardized for 12 exons of RB1 gene containing CGA codons at specific annealing temperatures in 20 mL reaction volume. The time and cost consumed for the amplification of 12 CGA codons by uPCR was calculated to be 36 hours and 9.78 US$ [ Table 2 ]. 
Multiplex PCR
The technique of multiplex PCR for 12 CGA codons of RB1 gene has been optimized under the conditions given in Table 1 . The time and cost consumed for the amplification of 12 CGA codons by mPCR was calculated to be 15 hours and 6.88 US$. mPCR is found to be cost and time saving when compared to uPCR, saving 58.3% of time and 29.6% of cost.
Discussion
Recognition of the retinoblastoma gene and the technology to identify point mutations within will make it possible to offer antenatal diagnosis to an increasing number of patients. These advances at the molecular level will help to determine whether a new mutation is of somatic or germinal origin and thereby identify gene carriers. uPCR strategies are useful for mutational screening of small genes or genes with mutational hotspots. But these strategies will not be cost or labour efficient when large or multiple genes, with many target Nearly half of these families are one-child families. [8] A rapid molecular diagnostic method for retinoblastoma susceptibility gene will be useful for these families in taking a decision about having another child. Du and Gallie used quantitative fluorescent mPCR for mutational screening of RB1 gene and detected mutations in 50% of retinoblastoma patients screened. [9] In a study of pituitary tumours, mPCR was used for identification of homozygous deletion of exons 20-24 of RB1 gene from pituitary tumour DNA that failed to express retinoblastoma protein. [10] Lohmann et al analysed DNA from peripheral blood of 24 unrelated bilateral retinoblastoma patients without gross structural abnormalities by mPCR and polyacrylamide gel electrophoresis. [11] Screening of 26% of the RB1 coding region identified germline mutations 3 out of 24 bilateral retinoblastoma patients. mPCR followed by heteroduplex analysis and sequencing has been used as an efficient screening method for retinoblastoma. [12] RB1 gene is composed of 27 exons with no mutation hotspots. But majority of single base substitutions (76%) in RB1 gene are recurrent CpG transitions at 12 of the 15 CGA codons within the open reading frame (in the exons 8 (2 sites), 10, 11, 13, 14 (2 sites), 15, 17 (2 sites), 18 and 23) of RB1 gene. [3, 7] It is assumed that mPCR strategy for the CGA containing exons will offer an advantage for the rapid mutational screening and mPCR. As per our knowledge, this is for the first time mPCR method has been optimized for CGA codons of RB1 gene; the purpose of our study is to facilitate rapid identification of RB1 mutations. We first screen CGA codons, which have 40-50% of mutations; if no mutation is detected then rest of the exons within the RB1 gene will be screened. Optimization of mPCRs that are designed for simultaneousamplification of multiple targets may prove beneficial for the RB1 diagnostics, which could have implications in genetic counselling.
